What is a walgreen clinic?
Walgreens, the country’s largest pharmacy chain, has begun a nationwide rollout of a new drug called Nuvigil, which is designed to help people stay alive after a serious illness.
Walgreens said the drug, available in three different formulations, is available for both patients and non-patients.
The pharmacy chain said in a statement that the company is testing Nuvigent in a variety of settings and “will share more information on the medication once all testing has concluded.”
Walmart also announced the launch of Nuvigor, a new treatment for opioid overdoses that can be dispensed through pharmacies.
The drug, a combination of fentanyl and morphine, is made by Pfizer and comes in four formulations.
Walgreen said the company expects to have the drug on shelves in the United States by March 2019.
Walmart said it has purchased Nuvgert, a similar drug to Nuvigient, from the manufacturer, AbbVie.
Abbvie has sold more than 100 million doses of Nivigil.
Alfa’s share of the U.S. market for Nuvogens surged from 2.6 percent in December to more than 11 percent this month, the company said.
Walgreen has been the subject of scrutiny in recent years for the safety of Nuggigent, the drug that Walgros has made available to Walgens, Walmart and other companies.
The company has been accused of withholding data that showed the drug was safe.
The drug’s maker, Pfizer, and other drugmakers have also been accused by regulators of selling Nuvigs for years and failing to adequately disclose that information.
In a lawsuit filed in November, a New York state jury found that WalGreens had made more than $1 billion in sales through its pharmacies.